These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Synthesis, biological evaluation, and molecular docking studies of novel 1-benzene acyl-2-(1-methylindol-3-yl)-benzimidazole derivatives as potential tubulin polymerization inhibitors. Wang YT, Qin YJ, Yang N, Zhang YL, Liu CH, Zhu HL. Eur J Med Chem; 2015 Jun 24; 99():125-37. PubMed ID: 26070164 [Abstract] [Full Text] [Related]
26. Design and synthesis of pyrazole-oxindole conjugates targeting tubulin polymerization as new anticancer agents. Kamal A, Shaik AB, Jain N, Kishor C, Nagabhushana A, Supriya B, Bharath Kumar G, Chourasiya SS, Suresh Y, Mishra RK, Addlagatta A. Eur J Med Chem; 2015 Mar 06; 92():501-13. PubMed ID: 25599948 [Abstract] [Full Text] [Related]
27. Synthesis and biological evaluation of imidazo[2,1-b][1,3,4]thiadiazole-linked oxindoles as potent tubulin polymerization inhibitors. Kamal A, Rao MP, Das P, Swapna P, Polepalli S, Nimbarte VD, Mullagiri K, Kovvuri J, Jain N. ChemMedChem; 2014 Jul 06; 9(7):1463-75. PubMed ID: 24715721 [Abstract] [Full Text] [Related]
28. Discovery of small molecule inhibitors that interact with γ-tubulin. Friesen DE, Barakat KH, Semenchenko V, Perez-Pineiro R, Fenske BW, Mane J, Wishart DS, Tuszynski JA. Chem Biol Drug Des; 2012 May 06; 79(5):639-52. PubMed ID: 22268380 [Abstract] [Full Text] [Related]
29. New 6- and 7-heterocyclyl-1H-indole derivatives as potent tubulin assembly and cancer cell growth inhibitors. La Regina G, Bai R, Coluccia A, Naccarato V, Famiglini V, Nalli M, Masci D, Verrico A, Rovella P, Mazzoccoli C, Da Pozzo E, Cavallini C, Martini C, Vultaggio S, Dondio G, Varasi M, Mercurio C, Hamel E, Lavia P, Silvestri R. Eur J Med Chem; 2018 May 25; 152():283-297. PubMed ID: 29730191 [Abstract] [Full Text] [Related]
34. Linkages in tubulin-colchicine functions: the role of the ring C (C') oxygens and ring B in the controls. Pérez-Ramírez B, Gorbunoff MJ, Timasheff SN. Biochemistry; 1998 Feb 10; 37(6):1646-61. PubMed ID: 9484236 [Abstract] [Full Text] [Related]
36. Synthesis and biological evaluation of 2-amino-3-(3',4',5'-trimethoxybenzoyl)-5-aryl thiophenes as a new class of potent antitubulin agents. Romagnoli R, Baraldi PG, Pavani MG, Tabrizi MA, Preti D, Fruttarolo F, Piccagli L, Jung MK, Hamel E, Borgatti M, Gambari R. J Med Chem; 2006 Jun 29; 49(13):3906-15. PubMed ID: 16789746 [Abstract] [Full Text] [Related]
37. Design, synthesis and biological evaluation of millepachine derivatives as a new class of tubulin polymerization inhibitors. Wang G, Peng F, Cao D, Yang Z, Han X, Liu J, Wu W, He L, Ma L, Chen J, Sang Y, Xiang M, Peng A, Wei Y, Chen L. Bioorg Med Chem; 2013 Nov 01; 21(21):6844-54. PubMed ID: 23993668 [Abstract] [Full Text] [Related]
38. CoMFA and docking studies of 2-phenylindole derivatives with anticancer activity. Liao SY, Qian L, Miao TF, Lu HL, Zheng KC. Eur J Med Chem; 2009 Jul 01; 44(7):2822-7. PubMed ID: 19167135 [Abstract] [Full Text] [Related]
39. Synthesis and biological evaluation of 1-methyl-2-(3',4',5'-trimethoxybenzoyl)-3-aminoindoles as a new class of antimitotic agents and tubulin inhibitors. Romagnoli R, Baraldi PG, Sarkar T, Carrion MD, Cara CL, Cruz-Lopez O, Preti D, Tabrizi MA, Tolomeo M, Grimaudo S, Di Cristina A, Zonta N, Balzarini J, Brancale A, Hsieh HP, Hamel E. J Med Chem; 2008 Mar 13; 51(5):1464-8. PubMed ID: 18260616 [Abstract] [Full Text] [Related]